Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Trastuzumab for small HER-2+ breast cancer: small tumor, big decision.

Trastuzumab for small HER-2+ breast cancer: small tumor, big decision. Oncologist. 2012; 17(4):508-11.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.